Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Guido, Cardona"'
Autor:
Jorge F, Maspero, Guido, Cardona, Patricia, Schonffeldt, Alberto, Tolcachier, Sandra N, González-Diaz, Anahi, Yañez, Clovis E, Galvao, Jerome, Msihid, Rebecca, Gall, Shahid, Siddiqui, Paul J, Rowe, Yamo, Deniz, Juby A, Jacob-Nara, Michel, Djandji
While advances in asthma care have been made in Latin America, there is still a large unmet need in patients with uncontrolled asthma. This post hoc analysis of the QUEST study assessed safety and efficacy of dupilumab in the subgroup of patients enr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2792369a4ed7305544e259207a7ab8
Autor:
Yuji Tohda, Yi Zhang, Elizabeth Laws, Alberto Papi, Linda B. Ford, Natalia M Nenasheva, Michael E. Wechsler, Ian D. Pavord, Leda Mannent, Upender Kapoor, Nikhil Amin, Asif H. Khan, Henrik Watz, Paul Rowe, Jorge Maspero, David Langton, Hae-Sim Park, Mario Castro, Marcella Ruddy, Arnaud Bourdin, Megan Hardin, Xuezhou Mao, Faisal A. Khokhar, Christian Domingo, Guido Cardona, Yamo Deniz, Kenneth R. Chapman
Publikováno v:
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2021, ⟨10.1016/S2213-2600(21)00322-2⟩
The Lancet Respiratory Medicine, Elsevier, 2021, ⟨10.1016/S2213-2600(21)00322-2⟩
Summary Background Clinical trials have shown treatment benefits of dupilumab in patients with uncontrolled asthma for up to 1 year. This study aimed to evaluate the long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828a5b08dc17d4200d31d0d5511c4a7f
https://hal.archives-ouvertes.fr/hal-03363008
https://hal.archives-ouvertes.fr/hal-03363008